Abstract
165 treatment-naive patients who first presented at the infectious disease clinic of the University Medical Center Hamburg-Eppendorf from 2009 to 2011 were retrospectively analyzed with emphasis on patients with late presentation (LP). In line with other recent German reports, there was a large proportion of 105 of the 165 treatment-naïve patients (63.6 %) who presented late. Old age, heterosexual transmission risk and migrant background were associated risk factors for late presentation. Thus, further intensified national efforts like the HIV in Europe initiative are needed to identify such patients at high risk for HIV infection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kittner JM, von Bialy L, Wiltink J, Thomaidis T, Gospodinov B, Rieke A, Katz F, Discher T, Rath K, Claus B, Held G, Friese G, Schappert B, Schuchmann M, Galle PR. Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohort. Infection. 2015;43(3):299–305.
Platten M, Linnemann R, Kummerle T, Jung N, Wyen C, Ehren K, Gravemann S, Gillor D, Cornely OA, Fischer J, Lehmann C, Rockstroh JK, Fatkenheuer G, Vehreschild JJ. Clinical course and quality of care in ART-naive patients newly presenting in a HIV outpatient clinic. Infection. 2014;42(5):849–57.
Spornraft-Ragaller P, Boashie U, Stephan V, Schmitt J. Analysis of risk factors for late presentation in a cohort of HIV-infected patients in Dresden: positive serology for syphilis in MSM is a determinant for earlier HIV diagnosis. Infection. 2013;41(6):1145–55.
Zoufaly A, an der Heiden M, Marcus U, Hoffmann C, Stellbrink H, Voss L, van Lunzen J, Hamouda O, G. ClinSurv Study. Late presentation for HIV diagnosis and care in Germany. HIV Med. 2012;13(3):172–81.
Ryom L, Boesecke C, Gisler V, Manzardo C, Rockstroh JK, Puoti M, Furrer H, Miro JM, Gatell JM, Pozniak A, Behrens G, Battegay M, Lundgren JD, E.G. Board. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons. HIV Med. 2015.
Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, Girardi E, Johnson M, Kirk O, Lundgren J, Mocroft A, D’Arminio Monforte A, Phillips A, Raben D, Rockstroh JK, Sabin C, Sonnerborg A, de Wolf F, G. European Late Presenter Consensus Working. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61–4.
Robert-Koch-Institute. http://www.rki.de/DE/Content/InfAZ/H/HIVAIDS/Epidemiologie/Daten_und_Berichte/EckdatenHamburg.pdf?__blob=publicationFile. Epidemiologic short report. 2013.
Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte A, Phillips AN, Sabin CA, Lundgren JD, D.A.D.S. Group. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384(9939):241–8.
MacCarthy S, Bangsberg DR, Fink G, Reich M, Gruskin S. Late presentation to HIV/AIDS testing, treatment or continued care: clarifying the use of CD4 evaluation in the consensus definition. HIV Med. 2014;15(3):130–4.
Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L, D.A.D.s. group, C. Royal Free Hospital Clinic, I.s. group, S.s. group, E.s. group. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015;12(3):e1001809.
O’Shea D, Ebrahim M, Egli A, Redmond D, McConkey S. Late presentation of HIV despite earlier opportunities for detection, experience from an Irish tertiary referral institution. Ir J Med Sci. 2013;182(3):389–94.
Agency HP. HIV in the United Kingdom: 2008 Report. London: Health Protection Agency. 2008.
Borghi V, Girardi E, Bellelli S, Angeletti C, Mussini C, Porter K, Esposito R. Late presenters in an HIV surveillance system in Italy during the period 1992–2006. J Acquir Immune Defic Syndr. 2008;49(3):282–6.
Sulis G, El Hamad I, Fabiani M, Rusconi S, Maggiolo F, Guaraldi G, Bozzi G, Bernardini C, Lichtner M, Stentarelli C, Carenzi L, Francisci D, Saracino A, Castelli F, HIV/Migrants Study Group. Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000–2010. Infection. 2014;42(5):859–67.
Acknowledgments
We thank the patients who participated in this study. JvL, OD, BK and JSW are supported by the German Center for Infection (DZIF) German Research. JSzW is supported by the German research agency (SFB841 project A6).
Conflict of interest
JvL has received speaker´s honoraria, served as an advisor and received project funding from Abbvie, Bionor AS, Boehringer; Bristol Myers-Squibb, Genetic Immunity, Gilead, GSK, Janssen-Cilag, MSD, Roche and Vision7, and is currently an employee of ViiV Healthcare. OD has received speaker´s honoraria from Gilead, MSD, Roche, Boehringer, Janssen-Cilag, Bristol Myers-Squibb, Bristol Myers-Squibb, GSK and ViiV. SS, AH, SH, GS and JSW have received speakers´ honoraria from Gilead, MSD and Roche.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schäfer, G., Kreuels, B., Schmiedel, S. et al. High proportion of HIV late presenters at an academic tertiary care center in northern Germany confirms the results of several cohorts in Germany: time to put better HIV screening efforts on the national agenda?. Infection 44, 347–352 (2016). https://doi.org/10.1007/s15010-016-0880-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-016-0880-4